Search

everythinglearnresearchcommunity

for

Search:↓

A multi-tiered treatment approach is crucial for managing hidradenitis suppurativa in patients with intellectual and developmental disorders.

CEFFE injections effectively and safely improve postinflammatory hyperpigmentation.

Betulinic acid can help treat hepatitis C by stopping virus replication.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Divalproex sodium significantly improved headaches in two-thirds of patients.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

A woman's hair loss worsened after starting hepatitis C treatment due to immune changes in her hair follicles.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Actemra is approved for a specific artery condition, HIV treatment adherence has improved, women may pay more for a hair loss product, and incorrect dosing of blood thinners can be risky.

Cetuximab can cause unusual hair growth and hair loss.

A patient with advanced kidney cancer and no hepatitis C developed skin inflammation due to a drug called interferon alpha-2a.

The new human placental extract may help prevent hair graying and reduce nerve pain from chemotherapy.

Honey and bee pollen can help reduce menopausal symptoms in breast cancer patients.

Patients with HR+/HER2- advanced breast cancer commonly experience fatigue, hair loss, and pain, which significantly affect daily activities.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

PROTACs offer a new, precise way to treat cancer by breaking down harmful proteins.

Gefitinib can cause rare scarring hair loss.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Cepharanthine may help treat gastric cancer by causing cancer cell death and affecting energy use.

A mycobacterial protein shares a similar region with a human skin protein, possibly affecting skin diseases.

Cyproterone acetate and ethinylestradiol effectively reduce hirsutism and acne in women.

Healthcare claims databases can help monitor drug safety, but may report adverse events differently than direct surveillance.

The folate-cyclodextrin conjugate targets cancer cells more precisely, potentially reducing chemotherapy side effects.

Heparin and protamine are promising in tissue repair and organ regeneration, including skin and hair.

Exosomes show promise for targeted treatment of HER2-positive breast cancer.